Navigation Links
'Electronic Nose' Sniffs Out Asthma
Date:4/7/2010

Experimental device tracks compounds in breath and bested standard test, study found

WEDNESDAY, April 7 (HealthDay News) -- Using an artificial breath-sensor system dubbed the "electronic nose," Italian researchers were able to spot more cases of asthma than with traditional diagnostic tools.

The electronic nose detected nearly 90 percent of people with asthma compared to about 70 percent who were accurately diagnosed in the traditional way with lung function tests, according to new research published in the April issue of the journal Chest.

When combined with another test, called the fractional exhaled nitric oxide (FENO) test, the electronic nose did an even better job at detecting asthma, the study found.

"The electronic nose discriminates between patients with asthma and healthy subjects and its performance is increased when combined with FENO," wrote the Italian team led by Dr. Paolo Montuschi of the Catholic University of the Sacred Heart in Rome.

The device works by identifying volatile organic compounds (VOCs) in exhaled breath. These VOCs produce a unique smell print for each individual and specific patterns are seen in people with asthma.

The new study included 27 people with intermittent or mild persistent asthma and 24 healthy people. None of the study volunteers had a history of smoking. Those with asthma had a history of allergies, and none had been treated with corticosteroids for at least four weeks prior to the start of the study.

Currently, asthma is diagnosed "based on your medical history and symptoms, and with spirometry (lung function testing) and exhaled nitric oxide," said Dr. Thomas Leath, director of allergy and immunology at Scott & White Healthcare in Round Rock, Texas.

The Italian researchers wanted to compare the electronic nose to the other commonly used tests -- spirometry and FENO -- to see which test was best at confirming a diagnosis of asthma.

To do this, all of the study volunteers were given all three tests. Each test is non-invasive, requiring only the use of exhaled air.

The electronic nose was able to correctly differentiate healthy people from those with physician-diagnosed asthma in 87.5 percent of the cases. FENO was able to correctly identify asthma in 79.2 percent of the study volunteers and lung function testing (spirometry) discerned just 70.8 percent of the people with asthma.

When the electronic nose and FENO were combined, the two tests together correctly identified almost 96 percent of the asthma cases.

"This is potentially a great tool. It could be used for screening if it's affordable or for seeing the affect of anti-inflammatory medicines. But, it definitely needs more research," said Leath.

Two other asthma experts agreed.

"This device is interesting and warrants a further look, but it still needs to be perfected and the researchers need to figure out its niche," said Dr. Jennifer Appleyard, chief of allergy and immunology at St. John Hospital and Medical Center in Detroit. "We need to know if it's good for diagnostics or for measuring improvements after treatment. In some diseases, you use blood markers to monitor treatment response. Could you use this to see if patients are responding? We also need to know if it's good for diagnosing all types of asthma."

Dr. David Rosenstreich, director of the division of allergy and immunology at Montefiore Medical Center in New York City, added: "An objective and fast test for diagnosing asthma would be helpful, and this test seems to be a non-invasive way of sampling for the underlying problem. This test seems relatively easy for patients and it does have potential, but they've only looked at a very narrow collection of people who have allergic asthma."

Both Appleyard and Leath noted that cost might initially limit the use of an electronic nose.

More information

Learn more about how asthma is currently diagnosed from the U.S. National Heart, Lung, and Blood Institute.



SOURCES: Thomas Leath, M.D., assistant professor of pediatrics, department of allergy and immunology, Texas A&M Health Sciences Center, College Station, Texas, and division director, allergy and immunology, Scott & White Healthcare, Round Rock, Texas; Jennifer Appleyard, M.D., chief, allergy and immunology, St. John Hospital and Medical Center, Detroit; David Rosenstreich, M.D., director, division of allergy and immunology, Montefiore Medical Center, New York City; April 2010, Chest


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Amphora's PatentSafe Electronic Laboratory Notebook Fully Supported on the Apple iPad
2. doeLegal Delivers Real-Time Analytics for Immediate Electronic Billing Control
3. Medical Transcription Services and Electronic Health Record Systems Provider, MxSecure, Relocates Headquarters to New, State-of-the-Art Facility
4. Aprima and ProviDyn, Inc. Partner to Provide Electronic Health Records to Georgia Medical Practices
5. Aprima and CyTek Corporation Partner to Provide Electronic Health Records to Physician Practices
6. Central Illinois Electronic Health Records Summit Coming in April; Medical Conference Offered In Three Central Illinois Locations
7. Tallahassee Memorial HealthCare Selects Allscripts Electronic Health Record and Practice Management for More Than 100 Providers
8. Irelands Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products
9. Electronic Cigarettes Continue to Experience Popularity Growth
10. HIMSS Electronic Health Record Association Responds to Proposed Meaningful Use and Certification Rules
11. Electronic Cigarettes Are Tobacco Products, States AAPHP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 2017 , ... Galena, Alaska, has a population of less than 500 people. ... was targeted to build a nuclear plant by the TOSHIBA Corporation. , In “The ... Yoder describes the journey to get power to his small town, off the electrical ...
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the largest ... James (Jim) Vertino as Chief Information Officer (CIO). He will be joining HealthSmart ... innovation and business performance. He defines strategic roadmaps by reimagining business processes—bridging the ...
(Date:5/21/2017)... ... May 21, 2017 , ... Florida Pain Relief Group, a division ... newest location at 109 Silver Palm Ave., Melbourne, on Monday, May 22. Initially the ... opening of the Melbourne practice, PPOA operates 23 pain management clinics in Florida and ...
(Date:5/19/2017)... ... May 19, 2017 , ... A leader in ... Charlotte recently began recruitment efforts for the inaugural cohort of its online ... knowledge and expertise to approach and address the unique nuances healthcare organizations face ...
(Date:5/19/2017)... FL (PRWEB) , ... May 19, 2017 , ... ... asset protection services and retirement planning assistance to families and business owners in ... Sclerosis Society to advocate for MS sufferers and their families. , Multiple sclerosis ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... May 15, 2017 Enterin Inc., a privately-held CNS ... developing novel compounds to treat Parkinson,s disease (PD), has enrolled ... a Phase 1/2a randomized, controlled, multicenter study involving patients with ... enroll 50 patients over a 9-to-12-month period. The first stage ... patients with PD. Participating sites include Denver ...
(Date:5/11/2017)... -- Thornhill Research Inc. ( Toronto, Ontario, Canada ... five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. Department ... ( Ottawa, Ontario, Canada ) to ... to patients requiring emergency medical procedures in a ... have been a longtime partner with Thornhill Research ...
Breaking Medicine Technology: